Episode Details

Back to Episodes
Pharmaceutical Executive Daily: Moderna Outlines Growth Plan at 2026 Analyst Day

Pharmaceutical Executive Daily: Moderna Outlines Growth Plan at 2026 Analyst Day

Published 6 days, 1 hour ago
Description
Moderna lays out an oncology-driven growth plan at its 2026 Analyst Day, Pfizer and Blackstone sign a co-funding deal worth up to $1.5 billion for berobenatide, and Parexel’s Stacy Hurt on how patients’ use of AI is reshaping sponsor communication.
Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us